Literature DB >> 11597910

Induction of c-jun and TGF-beta 1 in Fischer 344 rats during amiodarone-induced pulmonary fibrosis.

W H Chung1, B M Bennett, W J Racz, J F Brien, T E Massey.   

Abstract

Amiodarone (AM) is an antidysrhythmic agent with a propensity to cause pulmonary toxicity, including potentially fatal fibrosis. In the present study, the potential roles of c-Jun and transforming growth factor (TGF)-beta 1 in AM-induced inflammation and fibrogenesis were examined after intratracheal administration of AM (1.83 micromol/day on days 0 and 2) or an equivalent volume (0.4 ml) of distilled water to male Fischer 344 rats. Northern and immunoblot analyses demonstrated that lung TGF-beta 1 (mRNA and protein) expression was increased 1.5- to 1.8-fold relative to control during the early inflammation period and 1 day, 1 wk, and 2 wk post-AM treatment. Lung c-Jun protein expression was increased concomitantly with evidence of AM-induced fibrosis; at 5 wk post-AM treatment, c-Jun protein was increased 3.3-fold relative to control. The results indicate a role for induction of c-jun and TGF-beta 1 expression in the development of AM-induced pulmonary fibrosis in the Fischer 344 rat and provide potential targets for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11597910     DOI: 10.1152/ajplung.2001.281.5.L1180

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  8 in total

Review 1.  Animal models of drug-induced pulmonary fibrosis: an overview of molecular mechanisms and characteristics.

Authors:  Shuchan Li; Jianrong Shi; Huifang Tang
Journal:  Cell Biol Toxicol       Date:  2021-11-05       Impact factor: 6.819

2.  Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats.

Authors:  Durairaj Punithavathi; Narayanan Venkatesan; Mary Babu
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

3.  Pulmonary perfusion imaging in the rodent lung using dynamic contrast-enhanced MRI.

Authors:  Nilesh N Mistry; James Pollaro; Jiayu Song; Ming De Lin; G Allan Johnson
Journal:  Magn Reson Med       Date:  2008-02       Impact factor: 4.668

4.  Shared and Tissue-Specific Expression Signatures between Bone Marrow from Primary Myelofibrosis and Essential Thrombocythemia.

Authors:  Genta Ishikawa; Naoto Fujiwara; Hadassa Hirschfield; Lilian Varricchio; Yujin Hoshida; Giovanni Barosi; Vittorio Rosti; Maria Padilla; Maria Mazzarini; Scott L Friedman; Ronald Hoffman; Anna Rita Migliaccio
Journal:  Exp Hematol       Date:  2019-11-01       Impact factor: 3.084

5.  Comparison of Oral, Intranasal and Aerosol Administration of Amiodarone in Rats as a Model of Pulmonary Phospholipidosis.

Authors:  Aateka Patel; Ewelina Hoffman; Doug Ball; Jan Klapwijk; Rory T Steven; Alex Dexter; Josephine Bunch; Daniel Baker; Darragh Murnane; Victoria Hutter; Clive Page; Lea Ann Dailey; Ben Forbes
Journal:  Pharmaceutics       Date:  2019-07-17       Impact factor: 6.321

6.  Crucial Role of PLGA Nanoparticles in Mitigating the Amiodarone-Induced Pulmonary Toxicity.

Authors:  Amira Motawea; Dalia Alsaied Moustafa Ahmed; Ahmed A El-Mansy; Noha Mohamed Saleh
Journal:  Int J Nanomedicine       Date:  2021-07-08

7.  Effect of Aronia melanocarpa fruit juice on amiodarone-induced pneumotoxicity in rats.

Authors:  Stefka Valcheva-Kuzmanova; Galya Stavreva; Violeta Dancheva; Ljudmil Terziev; Milena Atanasova; Angelina Stoyanova; Anelia Dimitrova; Veneta Shopova
Journal:  Pharmacogn Mag       Date:  2014-04       Impact factor: 1.085

8.  A Mechanistic Study on the Amiodarone-Induced Pulmonary Toxicity.

Authors:  Bader Al-Shammari; Mohamed Khalifa; Saleh A Bakheet; Moustafa Yasser
Journal:  Oxid Med Cell Longev       Date:  2016-01-10       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.